Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma

Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma

Glioblastoma (GBM) is considered one of the most malignant, genetically heterogeneous, and therapy-resistant solid tumor. Therapeutic options are limited in GBM and involve surgical resection followed by chemotherapy and/or radiotherapy. Adjuvant therapies, including antiangiogenic treatments (AATs)...

Full description

Bibliographic Details
Main Authors:	Ali S. Arbab, Mohammad H. Rashid, Kartik Angara, Thaiz F. Borin, Ping-Chang Lin, Meenu Jain, Bhagelu R. Achyut
Format:	Article
Language:	English
Published:	MDPI AG 2017-12-01
Series:	International Journal of Molecular Sciences
Subjects:	tumor microenvironment Glioblastoma neovascularization antiangiogenic therapy resistance bone marrow-derived cells myeloid cells
Online Access:	https://www.mdpi.com/1422-0067/18/12/2732

Similar Items

Friends with Benefits: Chemokines, Glioblastoma-Associated Microglia/Macrophages, and Tumor Microenvironment
by: Elena Codrici, et al.
Published: (2022-02-01)

Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies
by: Boyuan Huang, et al.
Published: (2023-02-01)

The Interplay between Glioblastoma and Its Microenvironment
by: Mark Dapash, et al.
Published: (2021-08-01)

The Vascular Microenvironment in Glioblastoma: A Comprehensive Review
by: Alejandra Mosteiro, et al.
Published: (2022-05-01)

Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study.
by: Sehar Ali, et al.
Published: (2021-01-01)

A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia
by: Seyed Mohammadreza Bolandi, et al.
Published: (2021-10-01)

Therapeutic Targeting of Glioblastoma and the Interactions with Its Microenvironment
by: Vassilis Genoud, et al.
Published: (2023-12-01)

The immune cell landscape of glioblastoma patients highlights a myeloid-enriched and immune suppressed microenvironment compared to metastatic brain tumors
by: Beatrice Musca, et al.
Published: (2023-10-01)

Bone Marrow Microenvironment as a Source of New Drug Targets for the Treatment of Acute Myeloid Leukaemia
by: Kathryn A. Skelding, et al.
Published: (2022-12-01)

Myeloid Cells in Glioblastoma Microenvironment
by: Alessandra De Leo, et al.
Published: (2020-12-01)

ACAT1 deficiency in myeloid cells promotes glioblastoma progression by enhancing the accumulation of myeloid-derived suppressor cells
by: Mingjin Wang, et al.
Published: (2023-12-01)

BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS
by: Maria Teresa Voso, et al.
Published: (2023-08-01)

Cross Talk Between Macrophages and Cancer Cells in the Bone Metastatic Environment
by: Lena Batoon, et al.
Published: (2021-11-01)

The Role of Hypoxic Bone Marrow Microenvironment in Acute Myeloid Leukemia and Future Therapeutic Opportunities
by: Samantha Bruno, et al.
Published: (2021-06-01)

Spatiotemporal evolution of AML immune microenvironment remodeling and RNF149-driven drug resistance through single-cell multidimensional analysis
by: Xin Wu, et al.
Published: (2023-10-01)

Novel peptides derived from neuropeptide Y prevent chemotherapy-induced bone marrow damage by regulating hematopoietic stem cell microenvironment
by: Min Hee Park, et al.
Published: (2018-09-01)

Nanocarriers and nonviral methods for delivering antiangiogenic factors for glioblastoma therapy: the story so far
by: Clavreul A, et al.
Published: (2019-04-01)

Single-cell map of diverse immune phenotypes in the acute myeloid leukemia microenvironment
by: Rongqun Guo, et al.
Published: (2021-03-01)

The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia
by: Marilena Ciciarello, et al.
Published: (2019-10-01)

Recreating the Bone Marrow Microenvironment to Model Leukemic Stem Cell Quiescence
by: Eimear O’Reilly, et al.
Published: (2021-09-01)

Ovarian Hormones Regulate the Production of Adipocytes From Bone Marrow-Derived Cells
by: Kathleen M. Gavin, et al.
Published: (2018-05-01)

The immunosuppressive microenvironment and immunotherapy in human glioblastoma
by: Xuehua Zhang, et al.
Published: (2022-11-01)

Extracellular Vesicles and Chemotherapy Resistance in the AML Microenvironment
by: Jill Nehrbas, et al.
Published: (2020-02-01)

Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts
by: Yahaya A. Yabo, et al.
Published: (2024-04-01)

Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
by: Benjamin T. Himes, et al.
Published: (2021-10-01)

CXCR4 Antagonists as Stem Cell Mobilizers and Therapy Sensitizers for Acute Myeloid Leukemia and Glioblastoma?
by: Vashendriya V.V. Hira, et al.
Published: (2020-02-01)

Cancer Stem Cell-Associated Immune Microenvironment in Recurrent Glioblastomas
by: Yoshitaka Murota, et al.
Published: (2022-06-01)

Glioblastoma: Relationship between Metabolism and Immunosuppressive Microenvironment
by: Ainhoa Hernández, et al.
Published: (2021-12-01)

Glioblastoma Microenvironment and Cellular Interactions
by: Carmen-Bianca Crivii, et al.
Published: (2022-02-01)

Multiple Faces of the Glioblastoma Microenvironment
by: Alina Simona Șovrea, et al.
Published: (2022-01-01)

Decipher the Glioblastoma Microenvironment: The First Milestone for New Groundbreaking Therapeutic Strategies
by: Giuseppe Nicolò Fanelli, et al.
Published: (2021-03-01)

Systemic and local immunosuppression in glioblastoma and its prognostic significance
by: Aleksei A. Stepanenko, et al.
Published: (2024-02-01)

Exploring the intricate cross-talk between clonal expansion and the bone marrow niche
by: Steven Ngo, et al.
Published: (2024-03-01)

Far from Health: The Bone Marrow Microenvironment in AML, A Leukemia Supportive Shelter
by: Stephanie Sendker, et al.
Published: (2021-05-01)

Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development
by: Yiyi Yao, et al.
Published: (2021-07-01)

Glioblastoma Microenvironment and Invasiveness: New Insights and Therapeutic Targets
by: José Ignacio Erices, et al.
Published: (2023-04-01)

Eph-Ephrin Signaling Mediates Cross-Talk Within the Bone Microenvironment
by: Agnieszka Arthur, et al.
Published: (2021-02-01)

Combined Effects of Myeloid Cells in the Neuroblastoma Tumor Microenvironment
by: Jennifer Frosch, et al.
Published: (2021-04-01)

Bone Marrow Microenvironment-On-Chip for Culture of Functional Hematopoietic Stem Cells
by: Azmeer Sharipol, et al.
Published: (2022-06-01)

Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in Glioblastoma
by: Kartik Angara, et al.
Published: (2017-08-01)